| AE1/AE3 | Pan-cytokeratin antibody cocktail |
| ACG | American College of Gastroenterology |
| AFP | Alpha-fetoprotein |
| CEA | Carcinoembryonic antigen |
| CPS | Combined positive score |
| CT | Computed tomography |
| CUP | Carcinoma of unknown primary |
| EAC | Esophageal adenocarcinoma |
| ECOG | Eastern Cooperative Oncology Group |
| EDTA | Ethylenediaminetetraacetic acid |
| EGD | Esophagogastroduodenoscopy |
| ESCC | Esophageal squamous cell carcinoma |
| GEJ | Gastroesophageal junction |
| H&E | Hematoxylin and eosin |
| IHC | Immunohistochemistry |
| MRI | Magnetic resonance imaging |
| NCCN | National Comprehensive Cancer Network |
| OS | Overall Survival |
| PET-CT | Positron emission tomography–computed tomography |
| PSA | Prostate-specific antigen |
| PTHrP | Parathyroid hormone-related peptide |
| SCC | Squamous cell carcinoma |
| SEER | Surveillance, Epidemiology, and End Results |
| TTF-1 | Thyroid transcription factor-1 |
| cfDNA | Cell-free DNA |
| ctDNA | Circulating tumor DNA |
| NGS | Next-generation sequencing |